Flex4Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Flex4Pharma
Largest movements
- Financial fixed assets +€29,500
up €29,500 (+5900.0%), from €500 to €30,000
- Receivables within one year +€2,337
up €2,337 (+10.4%), from €22,508 to €24,845
of which Other amounts receivable: +€3,612
- Deferred charges and accrued income -€971
down €971 (-73.8%), from €1,316 to €345
- Other debts +€16,364
up €16,364 (+1163.4%), from €1,407 to €17,770
- Trade debts +€6,369
up €6,369 (+2065.9%), from €308 to €6,677
- Reserves +€3,711
up €3,711 (+15.4%), from €24,040 to €27,751
- Tax, wage and social debts +€2,324
up €2,324 (+774.8%), from €300 to €2,624
- Short-term financial debts +€1,688
new in 2025: €1,688
- Gross operating margin +€26,851
up €26,851 (+3986.3%), from €674 to €27,525
- Taxes +€7,624
new in 2025: €7,624
- Financial income -€1,037
down €1,037 (-100.0%), from €1,037 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €29,055 | €59,511 | +€30,456 | +104.8% |
| Fixed assets | 21/28 | €976 | €30,048 | +€29,072 | +2979.3% |
| Tangible fixed assets | 22/27 | €476 | €48 | -€428 | -89.9% |
| Furniture and vehicles | 24 | €476 | €48 | -€428 | -89.9% |
| Financial fixed assets | 28 | €500 | €30,000 | +€29,500 | +5900.0% |
| Current assets | 29/58 | €28,079 | €29,462 | +€1,384 | +4.9% |
| Amounts receivable within one year | 40/41 | €22,508 | €24,845 | +€2,337 | +10.4% |
| Trade receivables | 40 | €7,905 | €6,630 | -€1,275 | -16.1% |
| Other amounts receivable | 41 | €14,603 | €18,215 | +€3,612 | +24.7% |
| Cash at bank and in hand | 54/58 | €4,255 | €4,273 | +€18 | +0.4% |
| Deferred charges and accrued income | 490/1 | €1,316 | €345 | -€971 | -73.8% |
| Total equity and liabilities | 10/49 | €29,055 | €59,511 | +€30,456 | +104.8% |
| Equity | 10/15 | €27,040 | €30,751 | +€3,711 | +13.7% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €24,040 | €27,751 | +€3,711 | +15.4% |
| Distributable reserves | 133 | €24,040 | €27,751 | +€3,711 | +15.4% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €2,015 | €28,760 | +€26,745 | +1327.4% |
| Amounts payable within one year | 42/48 | €2,015 | €28,760 | +€26,745 | +1327.4% |
| Financial debts | 43 | - | €1,688 | +€1,688 | |
| Credit institutions | 430/8 | - | €1,688 | +€1,688 | |
| Trade debts | 44 | €308 | €6,677 | +€6,369 | +2065.9% |
| Suppliers | 440/4 | €308 | €6,677 | +€6,369 | +2065.9% |
| Taxes, remuneration and social security | 45 | €300 | €2,624 | +€2,324 | +774.8% |
| Taxes | 450/3 | €300 | €2,624 | +€2,324 | +774.8% |
| Other amounts payable | 47/48 | €1,407 | €17,770 | +€16,364 | +1163.4% |
| Non-recurring operating income | 76A | - | €14,500 | +€14,500 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €428 | €428 | = | 0.0% |
| Other operating charges | 640/8 | €451 | €465 | +€14 | +3.2% |
| Gross operating margin | 9900 | €674 | €27,525 | +€26,851 | +3986.3% |
| Operating profit (loss) | 9901 | -€205 | €26,632 | +€26,837 | |
| Financial income | 75/76B | €1,037 | €0 | -€1,037 | -100.0% |
| Recurring financial income | 75 | €1,037 | €0 | -€1,037 | -100.0% |
| Financial charges | 65/66B | €113 | €297 | +€183 | +162.3% |
| Recurring financial charges | 65 | €113 | €297 | +€183 | +162.3% |
| Profit (loss) for the period before taxes | 9903 | €718 | €26,335 | +€25,617 | +3565.6% |
| Income taxes | 67/77 | - | €7,624 | +€7,624 | |
| Profit (loss) for the period | 9904 | €718 | €18,711 | +€17,993 | +2504.4% |
| Profit (loss) for the period to be appropriated | 9905 | €718 | €18,711 | +€17,993 | +2504.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.